AG
ZOM

Advisor Group’s Zomedica Corp. ZOM Stock Holding History

Advisor Group’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Buy
+1,000
New +$336 ﹤0.01% 5552

Other funds holding ZOM

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
JA
JVL Associates Wyoming, Michigan $352M AUM 27.55% 1-Year Est. Return
RIS
Retirement Income Solutions Ann Arbor, Michigan $581M AUM 19.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Advisor Group's ZOM Position: Q4 2019 in Review

Advisor Group opened a new position in Zomedica Corp. (ZOM) in Q4 2019: 1,000 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #5552 among its holdings.

21 funds tracked by Wall St. Rank hold ZOM as of Q4 2019.

  • Advisor Group held 1,000 shares of Zomedica Corp. worth $0 as of Q4 2019.
  • Zomedica Corp. was a new Advisor Group position in Q4 2019.
  • Zomedica Corp. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5552 holding.
  • 21 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.